articaine

Trade name: Septocaine

Small moleculeapproved

Approved

Apr 3, 2000

Articaine is a dental local anesthetic, which is the most widely used in a number of European countries and is available in many countries around the world. Articaine in combination with epinephrine under the brand name Septocaine is indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures. Local anesthetics block the generation and conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rising of the action potential. In general, the progression of anesthesia is related to the diameter, myelination, and conduction velocity of the affected nerve fibers. Articaine blocks the actions on Na+ channels. Epinephrine is a vasoconstrictor added to articaine HCl to slow absorption into the general circulation and thus prolong maintenance of an active tissue concentration. — NCATS

Clinical trial activity

77 trials · 56 clinical orgs · 6 marketing orgs

Phase 1
11
Phase 2
20
Phase 3
10
Phase 4
26

Earliest trial started Nov 1, 2005 (NCT00247741)

Timeline

2000s

  1. Apr 3, 2000

    Deproco — Earliest FDA Approval

  2. Apr 3, 2000

    Deproco — NDA Secondary Org

  3. Apr 3, 2000

    Deproco — NDA Organization

  4. Jan 1, 2005

    Earliest Phase 3 Sponsor(trial)

2010s

  1. Feb 26, 2010

    Pierrel Research — NDA Secondary Org

  2. Jun 18, 2010

    Hospira — Marketing Organization

  3. Jan 1, 2012

    Earliest Phase 1 Sponsor(trial)

  4. Jul 11, 2017

    HansaBioMed — Marketing Organization

  5. Jul 11, 2017

    Lonza — Marketing Organization

  6. Jan 1, 2018

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Aug 15, 2025

    Thea Pharma — Marketing Organization

Indications

Mechanism of action

Combination products

  • septocaine

    with epinephrine

    Also known as orabloc, ultacan, ultacan forte

Approval history

  • approvedApr 3, 2000

Chemistry & pharmacology

Loading structure…

SMILES

CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC
Mol. weight
284.38 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Racemic Mixture
Inorganic
No
Polymer
No
Delivery
Parenteral
Availability
Prescription Only

Oral

No

Parenteral

Yes

Topical

No

Sources

Also known as

  • 40045
  • 40 045
  • articaine
  • articaine
  • articaine
  • articaine
  • articaine
  • articaine
  • articaine
  • articaine
  • articaine
  • articaine hcl
  • articaine hcl
  • articaine hcl
  • articaine hydrochloride
  • articaine hydrochloride
  • articaine hydrochloride
  • carticaine
  • carticaine
  • carticaine
  • hoe-045
  • hoe-045
  • septanest
  • septanest
  • septocaine
  • septocaine
  • septocaine
  • ultracaine
  • ultracaine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07231614Phase 4Dec 20, 2025Universidad Austral de Chile
NCT07066306N/AJun 21, 2025Bezmialem University
NCT06980363Phase 1Jun 1, 2025Fayoum University
NCT06927726N/AJan 10, 2025Tanta University
NCT07145879N/AJan 1, 2025Pamukkale University
NCT06630819N/ANov 3, 2024Qassim University
NCT06461143N/AAug 21, 2024Istanbul University
NCT06423859N/AFeb 1, 2024Benha University
NCT06538233Phase 2Jan 1, 2024Cleveland Dental Institute
NCT06564987Phase 1Jan 1, 2024Cleveland Dental Institute
NCT06119139N/ADec 31, 2023Cairo University
NCT06047366Phase 4Dec 5, 2023Indiana University, United States Army
NCT06161714Phase 4Nov 30, 2023Riyadh Elm University
NCT05908305Phase 4Jun 10, 2023University of Algiers
NCT05839548Phase 3Jun 1, 2023Qassim Health Cluster, Qassim University
NCT05944341N/AJun 1, 2023Minia University
NCT05840913Phase 2Apr 30, 2023Government of Pakistan
NCT06679660N/AFeb 20, 2023Cukurova University
NCT05728151N/AFeb 12, 2023Research Institute of Ophthalmology, Egypt
NCT06862570Phase 2Dec 19, 2022Pakistan Army
Showing 20 of 77 trials
Page 1 / 4

Organizations

Research & Development (56)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Cairo UniversityAcademic/Hospital101032014
American Genomics, LLCAcademic/Hospital5522020
Minia UniversityAcademic/Hospital3322019
Netherlands Institute for Pigment DisordersAcademic/Hospital3312014
University of AmsterdamAcademic/Hospital3012014
University of HelsinkiAcademic/Hospital3312009
University of Sao PauloAcademic/Hospital3322010
Virginia Commonwealth UniversityAcademic/Hospital3312019
Ain Shams UniversityAcademic/Hospital2212019
Cleveland Dental InstituteAcademic/Hospital2222024
Fayoum UniversityAcademic/Hospital2222022
Fundação de Amparo à Pesquisa do Estado de São PauloAcademic/Hospital2012010
Qassim UniversityAcademic/Hospital2122023
Taibah UniversityAcademic/Hospital2222017
Tishreen UniversityAcademic/Hospital2212022
University of MichiganAcademic/Hospital2212011
Ahl al-Bayt UniversityAcademic/Hospital1112021
Altinbas UniversityAcademic/Hospital1112015
American Association of EndodontistsAcademic/Hospital1012013
Anfomed GmbHFor profit1012017
56 organizations
Page 1 / 3

Marketing (7)

OrganizationOrg typeRelationshipDate
DeprocoFor profitNDA2Apr 3, 2000
DeprocoFor profitNDAApr 3, 2000
HansaBioMedFor profitMKTGJul 11, 2017
HospiraFor profitMKTGJun 18, 2010
LonzaFor profitMKTGJul 11, 2017
Pierrel ResearchFor profitNDA2Feb 26, 2010
Thea PharmaFor profitMKTGAug 15, 2025